SGSH gene therapy (NeuroGT)

N/A

Report date: 2025/06/11 10:57:39

Base Information

Drug NameSGSH gene therapy (NeuroGT)

Drug Alias NameN/A

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of ActionN-sulphoglucosamine sulphohydrolase modulators

TargetsN-sulphoglucosamine sulphohydrolase

Therapy Area/IndicationsMucopolysaccharidosis III

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNeuroGT Inc

China Registration ClassN/A

Active CompaniesNeuroGT Inc

Inactive CompaniesN/A

Active IndicationsMucopolysaccharidosis III

Inactive IndicationsN/A

ATC CodeN/A